Raymond James Downgrades Regeneron Pharma (REGN) to Underperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Raymond James Downgrades Regeneron Pharma (REGN) to Underperform

Regeneron's (REGN) Oncology Portfolio Likely to Continue to Struggle - Raymond James

October 26, 2022 11:24 AM EDT

Regeneron Pharmaceuticals (NASDAQ: REGN) has been downgraded to Underperform from Market Perform by Raymond James analyst Dane Leone on Wednesday.

In a note to clients, Leone explained the downgrade is based on three points, including the company's oncology portfolio likely struggling next... More